Page last updated: 2024-08-25

7-hydroxystaurosporine and Carcinoma, Squamous Cell

7-hydroxystaurosporine has been researched along with Carcinoma, Squamous Cell in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's6 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ensley, JF; Gutkind, JS; Igishi, T; Kremer, M; Lahusen, T; Leethanakul, C; Patel, V; Quintanilla-Martinez, L; Sausville, EA; Senderowicz, AM1
Hui, ZG; Li, YX; Wu, JX; Yang, WZ; Yu, ZH1
Amornphimoltham, P; Benavides, F; Conti, CJ; Gutkind, JS; Molinolo, AA; Patel, V; Sauk, J; Sausville, EA; Sriuranpong, V1
Bhawal, UK; Kuniyasu, H; Mitani, Y; Nomura, Y; Otsubo, A; Ozawa, K; Sugiyama, M1
Akinaga, S; Gomi, K; Nomura, K; Okabe, M1
Akinaga, S; Akiyama, T; Mizukami, T; Okabe, M; Shimizu, M; Tsujita, T; Yoshida, T1
Alfieri, AA; Sommers, GM1
Akinaga, S; Akiyama, T; Okabe, M; Shimizu, M; Tamaoki, T1
Akinaga, S; Akiyama, T; Eastman, A; Shimizu, M; Sugiyama, K; Takahashi, R; Tamaoki, T; Yamaguchi, K1
Danenberg, KD; Danenberg, PV; Grem, JL; Kao, V; Nguyen, D1

Other Studies

10 other study(ies) available for 7-hydroxystaurosporine and Carcinoma, Squamous Cell

ArticleYear
Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:11

    Topics: 3T3 Cells; Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cyclin D3; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Inhibitory Concentration 50; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Prognosis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; S Phase; Staurosporine; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002
[Abrogation of radiation-induced G2 arrest and radiosensitization by 7-hydroxystaurosporine (UCN-01) in human nasopharyngeal carcinoma cell line].
    Ai zheng = Aizheng = Chinese journal of cancer, 2003, Volume: 22, Issue:1

    Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; G2 Phase; Genes, p53; Humans; Mutation; Nasopharyngeal Neoplasms; Protein Kinase C; Radiation-Sensitizing Agents; Staurosporine

2003
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-15, Volume: 10, Issue:12 Pt 1

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Disease Progression; Enzyme Activation; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mouth Mucosa; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin; Staurosporine; Time Factors

2004
UCN-01 (7-hydroxystaurosporine) induces apoptosis and G1 arrest of both primary and metastatic oral cancer cell lines in vitro.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 103, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; G1 Phase; Humans; Mouth Neoplasms; Protein Kinase C; Protein Kinase Inhibitors; Staurosporine

2007
Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.
    Cancer chemotherapy and pharmacology, 1994, Volume: 33, Issue:4

    Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; DNA, Neoplasm; Humans; Protein Kinase C; Staining and Labeling; Staurosporine; Time Factors; Tumor Cells, Cultured

1994
G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Cancer research, 1997, Apr-15, Volume: 57, Issue:8

    Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Squamous Cell; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; G1 Phase; Humans; Microtubule-Associated Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Retinoblastoma Protein; RNA, Messenger; Staurosporine; Tumor Cells, Cultured; Tumor Suppressor Proteins

1997
Multimodality therapy: radiation and continuous concomitant cis-platinum and PKC inhibition in a cervical carcinoma model.
    Cancer investigation, 1998, Volume: 16, Issue:7

    Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Enzyme Inhibitors; Female; HeLa Cells; Humans; Protein Kinase C; Radiotherapy Dosage; Spheroids, Cellular; Staurosporine; Tumor Stem Cell Assay; Uterine Cervical Neoplasms

1998
Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole.
    Anti-cancer drugs, 1999, Volume: 10, Issue:1

    Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Squamous Cell; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Cell-Free System; Cyclin B; Cyclin B1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mitosis; Nocodazole; Phosphoprotein Phosphatases; Phosphorylation; Proteins; Skin Neoplasms; Staurosporine; Tumor Cells, Cultured; Tyrosine

1999
UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation.
    International journal of cancer, 2000, Mar-01, Volume: 85, Issue:5

    Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Drug Synergism; Female; G2 Phase; Genes, p53; Humans; In Situ Nick-End Labeling; Mitomycin; Protein Kinases; S Phase; Staurosporine; Tumor Cells, Cultured

2000
Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
    Anti-cancer drugs, 2002, Volume: 13, Issue:3

    Topics: Alkaloids; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Deoxyribonucleotides; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Drug Combinations; Enzyme Inhibitors; Floxuridine; Genes, p53; Humans; Lung Neoplasms; Polymerase Chain Reaction; RNA, Messenger; Staurosporine; Thymidylate Synthase; Tumor Cells, Cultured

2002